Phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for refractory relapsed small cell lung cancer (SCLC): North Japan Lung Cancer Group 0802.

被引：0
|
作者：
Saito, Ryota
Inoue, Akira
Sugawara, Shunichi
Oizumi, Satoshi
Maemondo, Makoto
Okudera, Koichi
Suzuki, Toshiro
Usui, Kazuhiro
Harada, Masao
Morikawa, Naoto
Hasegawa, YUkihiro
Ishimoto, Osamu
Sakakibara, Tomohiro
Asahina, Hajime
Nukiwa, Toshihiro
机构：
[1] Tohoku Univ Hosp, Sendai, Miyagi, Japan
[2] Sendai Kousei Hosp, Sendai, Miyagi, Japan
[3] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan
[4] Miyagi Canc Ctr, Natori, Miyagi 9811293, Japan
[5] Hirosaki Chuo Hosp, Hirosaki, Aomori, Japan
[6] Iwate Isawa Hosp, Oushu, Japan
[7] Kanto Med Ctr NTT EC, Tokyo, Japan
[8] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[9] Tohoku Kosei Nenkin Hosp, Sendai, Miyagi, Japan
[10] Aomori Prefectural Cent Hosp, Aomori, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7086
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
    Pietanza, M. Catherine
    Travis, William D.
    Chan, Timothy A.
    Ginsberg, Michelle S.
    Kris, Andrei Holodny Mark G.
    Krug, Lee M.
    PANCREAS, 2010, 39 (02) : 279 - 279
  • [42] Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naIve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901
    Morikawa, Naoto
    Inoue, Akira
    Sugawara, Shunichi
    Maemondo, Makoto
    Harada, Toshiyuki
    Harada, Masao
    Fujita, Yuka
    Katoh, Terufumi
    Yokouchi, Hiroshi
    Watanabe, Hiroshi
    Usui, Kazuhiro
    Suzuki, Toshiro
    Sakakibara-Konishi, Jun
    Nagai, Hiroki
    Kanbe, Mariko
    Nukiwa, Toshihiro
    LUNG CANCER, 2017, 111 : 38 - 42
  • [43] Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402
    Inoue, Akira
    Sugawara, Shunichi
    Yamazaki, Koichi
    Maemondo, Makoto
    Suzuki, Toshiro
    Gomi, Kazunori
    Takanashi, Shingo
    Inoue, Chieko
    Inage, Minoru
    Yokouchi, Hiroshi
    Watanabe, Hiroshi
    Tsukamoto, Toumei
    Saijo, Yasuo
    Ishimoto, Osamu
    Hommura, Fumihiro
    Nukiwa, Toshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) : 5401 - 5406
  • [44] Multicentre phase II study of carboplatin (AUC 5) and vinorelbine in small cell lung cancer (SCLC)
    Dunlop, DJ
    O'Brien, ME
    Lee, SM
    Hill, S
    Thatcher, N
    BRITISH JOURNAL OF CANCER, 2000, 83 : 42 - 42
  • [45] Carboplatin-etoposide in elderly small cell lung cancer (SCLC) patients: A phase II study
    Larive, S
    Bombaron, P
    ANNALS OF ONCOLOGY, 1998, 9 : 105 - 105
  • [46] Phase II study of weekly cisplatin, etoposide and irinotecan (PE/CPT) for refractory relapsed small cell lung cancer (SCLC).
    Kim, Y.
    Goto, K.
    Nishiwaki, Y.
    Kubota, K.
    Omatsu, H.
    Tamura, T.
    Ohe, Y.
    Kunitoh, H.
    Sekine, I.
    Yamamoto, N.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 386S - 386S
  • [47] A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR UNTREATED PATIENTS WITH EXTENSIVE-DIASESE SMALL CELL LUNG CANCER
    Motoshima, Kohei
    Ogawara, Daiki
    Takemoto, Shinnosuke
    Mizoguchi, Kosuke
    Ikeda, Takaya
    Fukuda, Minoru
    Nakatomi, Katsumi
    Nagashima, Seiji
    Nakamura, Yoichi
    Kono, Shigeru
    ANNALS OF ONCOLOGY, 2014, 25
  • [48] Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial
    Chiyoe Kitagawa
    Hideo Saka
    Shigehisa Kajikawa
    Kouki Mori
    Masahide Oki
    Ryujiro Suzuki
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1379 - 1385
  • [49] Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial
    Kitagawa, Chiyoe
    Saka, Hideo
    Kajikawa, Shigehisa
    Mori, Kouki
    Oki, Masahide
    Suzuki, Ryujiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1379 - 1385
  • [50] Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702
    Inoue, Akira
    Sugawara, Shunichi
    Maemondo, Makoto
    Mori, Yoshiaki
    Oizumi, Satoshi
    Harada, Masao
    Taima, Kageaki
    Morikawa, Naoto
    Ishida, Takashi
    Kinoshita, Ichiro
    Watanabe, Hiroshi
    Suzuki, Toshiro
    Nakagawa, Taku
    Saito, Ryota
    Nukiwa, Toshihiro
    LUNG CANCER, 2015, 89 (01) : 61 - 65
12345